Compare Cassava Sciences Inc (FLNA) vs Yum! Brands, Inc. (YUM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs Yum! Brands, Inc. — how do they compare? Cassava Sciences Inc trades at $1.07 (market cap $53.14M), while Yum! Brands, Inc. trades at $152.08 (market cap $42.05B). The key difference: Yum! Brands, Inc. is far larger — about 791.3× Cassava Sciences Inc's market cap, and Yum! Brands, Inc. pays a 1.97% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.
| FLNA | YUM | |
|---|---|---|
Market Cap | $53.14M | $42.05B |
Sector | Health | Consumer Cyclical |
52-Week High | $4.64 | $168.16 |
52-Week Low | $1.09 | $138.21 |
Enterprise Value | -$33.43M | $53.32B |
Dividend Yield | — | 1.97% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.
Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.
YUM Brands trades at $152.32, down 3.73% amid a food safety investigation at Taco Bell. Technical indicators show bearish momentum with support at $151 and resistance at $154. Fundamentally, revenue grew to $8.21B in 2025 with a net income margin of 20.48%, while the P/E ratio stands at 24.61. The company recently announced the $2.7B sale of Pizza Hut to focus on KFC and Taco Bell, alongside a $4B share buyback authorization.
The outlook remains cautious due to near-term headwinds from the health probe, but long-term growth prospects are supported by brand focus and capital returns. Risks include regulatory scrutiny and integration challenges from the divestiture. Analysts maintain a consensus price target of $174.60 with 37% buy ratings, suggesting potential upside if operational stability is restored.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About Yum! Brands, Inc.
Yum Brands is a U.S.-based restaurant operator featuring a portfolio of four brands: KFC (26,930 global units), Pizza Hut (18,380 units), Taco Bell (7,790 units), and The Habit Burger (310 units) at year-end 2021. With $58 billion in 2021 systemwide sales, the firm is the second-largest restaurant company in the world, behind McDonald's ($112.5 billion) but ahead of Restaurant Brands International ($36 billion) and Starbucks ($25 billion). Yum is 98% franchised, with the largest franchisee, Yum China, created via a 2016 spinoff transaction (after which Yum China agreed to pay 3% royalties to Yum Brands in perpetuity). Yum is the newest evolution of Tricon Brands, formerly a division of PepsiCo, and generates the bulk of its revenue from franchise royalties and marketing contributions.
Read more on YUM →
